Home › Stocks › GENB › All Fund Holders
GENB — GENERATE BIOMEDICINES INC · All Fund Holders
Funds holding (latest): 27 · Reported value held: $326.87M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 5.22M | $88.09M | 0.00% | Add |
| Capital World Investors history | Q2 2026 | 4.22M | $71.12M | 0.01% | Add |
| Norges Bank Investment Management history | Q2 2026 | 2.09M | $35.34M | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 1.66M | $28.00M | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 1.41M | $23.84M | 0.00% | New |
| ARK Invest history | Q2 2026 | 1.28M | $21.67M | 0.14% | Add |
| Harvard Management Company history | Q2 2026 | 1.11M | $18.74M | 0.91% | Hold |
| Geode Capital Management history | Q2 2026 | 735.00K | $12.40M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 377.99K | $6.38M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 326.27K | $5.50M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 224.60K | $3.79M | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 197.54K | $3.33M | 0.00% | New |
| Manulife Financial history | Q2 2026 | 84.80K | $1.43M | 0.00% | Add |
| D. E. Shaw & Co history | Q1 2026 | 95.00K | $1.19M | 0.00% | New |
| Balyasny Asset Management history | Q1 2026 | 79.49K | $993.61K | 0.00% | New |
| BNY Mellon history | Q2 2026 | 57.33K | $967.09K | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 55.43K | $935.10K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 39.69K | $669.49K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 30.59K | $516.00K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 24.14K | $407.16K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 23.30K | $393.11K | 0.00% | Add |
| Millennium Management history | Q2 2026 | 21.93K | $369.89K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 18.37K | $309.97K | 0.00% | New |
| Invesco Ltd history | Q2 2026 | 13.09K | $220.78K | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 11.18K | $188.66K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 2.37K | $40.04K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 2.16M | $36.38K | 0.00% | Add |